Found 7318 matches for
The University of Oxford and Bayer HealthCare have entered into a strategic research alliance in the area of gynaecological therapies. The multi-target collaboration focuses on endometriosis and uterine fibroids with the goal of discovering and developing innovative treatment options for these diseases. The alliance is for an initial period of two years, but is open for extension to up to five years.
The aim of this study is to evaluate the effect of different antihypertensive drugs in women with pregnancy hypertension on maternal and fetal/neonatal outcomes.
Open now! The RETHINK Study is a study that aims to see if we can detect those women who may find extra support for early labour useful, to help reduce their chance of a difficult labour and unnecessary intervention. To date research has not shown the best way to support women who are in early labour at home.
Open now! The Pfizer Maternal C-19 Vaccine Trial at Oxford University Hospitals NHS Foundation Trust for women between 24-34 weeks pregnant. The Nuffield Department of Women’s & Reproductive Health’s team of doctors, research midwives and nurses are delivering this critical trial to evaluate the safety, tolerability, and immunogenicity of the Pfizer vaccine in pregnant women.
A virtual networking event for women's health researchers at the University of Oxford and Edinburgh University, on Wednesday 9th June 2021. Book now!
The All-Party Parliamentary Group (APPG) on Endometriosis was launched in 2018 to raise awareness of endometriosis in Parliament, investigate how those who suffer from the condition can receive the support they need, and inquire into whether women are given an informed choice about the treatment options available for endometriosis and fibroids.